Horsham, PA – September 25, 2019 Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, announced the appointment of Dominick Vietri as its new President.

Vietri will oversee the day-to-day operations of the global organization. Vietri will provide global leadership and strategic direction to enhance the organization’s objectives to becoming a High-Performance Organization, which will deliver excellence, drive growth, and high-performance culture to our clients.

Vietri brings over 25 years of executive management and leadership experience in operations, sales, and marketing, across small to midsize wireless telecommunication, technology, and Fortune 500 companies.

Prior to Ancillare, Vietri held numerous executive and senior leadership positions, including Executive Vice President at Medifast a subsidiary of Jason Pharmaceuticals, Vice President of Sales at OfficeMax, Regional Vice President and General Manager at Canon Business Solutions, Chief Operations Officer at Intergis, Chief Executive Officer and President at Accelacom, Area Vice President and General Manager at XO Communications Group Vice President and General Manager at AT&T Wireless Services, and earlier in his career, Vietri held various positions at XEROX Corporation.

 “Vietri’s extensive executive leadership experience will strengthen our ability to deliver the best-in-class clinical and ancillary supply chain management services for our clients,” said Dr. Joanne Santomauro, Chief Executive Officer. “Vietri will be an integral part in moving our organization’s mission and vision forward.”

Vietri succeeds Jonathan Santomauro, who has moved to Chief Strategy Officer for the organization.

 

About Ancillare, LP

Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine.